Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
5 studies found for:    paratek
Show Display Options
Rank Status Study
1 Terminated Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Condition: Skin Diseases, Infectious
Interventions: Drug: PTK 0796;   Drug: linezolid
2 Withdrawn Phase 3 Study - Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI)
Condition: Skin Structures and Soft Tissue Infections
Interventions: Drug: PTK 0796;   Drug: Linezolid
3 Recruiting Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI
Conditions: Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: Omadacycline;   Drug: Linezolid
4 Active, not recruiting Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)
Conditions: Bacterial Pneumonia;   Community-Acquired Infections
Interventions: Drug: Omadacycline;   Drug: Moxifloxacin
5 Completed Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)
Conditions: Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: Omadacycline;   Drug: Linezolid

Study has passed its completion date and status has not been verified in more than two years.